Bristol Myers CEO signals dealmaking will be a top priority in 2025
Is Bristol Myers Squibb ready to take on big dealmaking again? When CEO Chris Boerner took over in late 2023, Bristol Myers was in a difficult position. Its stock price {$BMY} was down more than ...
Is Bristol Myers Squibb ready to take on big dealmaking again?
When CEO Chris Boerner took over in late 2023, Bristol Myers was in a difficult position. Its stock price {$BMY} was down more than ...
